Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC).
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Celgene
NCT07550673 · Acute Severe Ulcerative Colitis
NCT06372613 · Ulcerative Colitis in Histologic Remission
NCT07374471 · Ulcerative Colitis (UC)
NCT05739864 · Active Ulcerative Colitis
NCT06071312 · Clostridium Difficile, Ulcerative Colitis
Arizona Digestive Health
Sun City, Arizona
Adobe Clinical Research LLC
Tucson, Arizona
Arkansas Gastroenterology, P.A.
North Little Rock, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions